KAZALCI OKOLJA

You are here

Key message
Bad

Data for Slovenia show that the number of newly diagnosed cases of melanoma is increasing and that the increase is higher for female than for male population. Most cases of melanoma are most likely associated with acute, occasional and excessive sun exposure, especially in childhood. Melanoma is generally more common among northern European population. However, data for 2012 show that Slovenia is above the EU-27 average (depending on the value of age-standardized incidence rates) for female and male population. EU-27 average is 13.2/100,000 cases for males and 13.1/100,000 cases for females.



Charts

Figure ZD13-1: Crude incidence rate of malignant melanoma in adults, male and female, age 0-55, in the period 1999-2009 in Slovenia
Sources: 

Cancer Registry of RS (www.slora.si), 2013.

Show data
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Male number of cases per 100.000 7.7 5.4 7.4 7 5.9 9.2 9.9 5.9 9.3 10.7
Female number of cases per 100.000 8.3 8.1 6.2 8.9 9.8 10.4 12.1 10.1 13 17
2008 2009
Male number of cases per 100.000 10.5 10.1
Female number of cases per 100.000 14.9 15.7
Figure ZD13-2: Age-standardized incidence rate (ASR) cutaneous melanoma in adults younger than 55 years in selected European countries in 2008
Sources: 

WHO, 2009a.

Show data
Greece Bulgaria Romania Latvia Portugal Poland Slovakia Hungary Spain Estonia
ASR - Male number of cases per 100.000 inhab. 1.6 2.4 2.2 1.5 2.1 2.2 3 3.1 3.4 2.3
SR - Female number of cases per 100.000 inhab. 2 2.1 2.4 2.5 2.6 2.7 3.1 3.6 3.7 4.1
Italy Finland Czech Republic Germany Slovenia Ireland United Kingdom Lithuania Sweden France
ASR - Male number of cases per 100.000 inhab. 4.9 4.1 4.1 4.7 5.5 3.3 4.1 1.6 5.9 4.8
SR - Female number of cases per 100.000 inhab. 4.6 5 5.8 5.9 5.9 6.1 6.8 7.1 8.6 8.9
Netherlands Denmark Austria Norway Switzerland Iceland
ASR - Male number of cases per 100.000 inhab. 6.4 6.9 6.1 9.1 6.3 5.5
SR - Female number of cases per 100.000 inhab. 9.2 9.8 10 10.5 10.9 16.4

Goals




TWITTER